相关实验视频
Updated: May 13, 2026
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
27.9K
基于虚拟高血压回拉压梯度的诺莫图,用于预测在支架植入后PCI后低于最佳的QFR结果
Xingqiang He1,2, Tsai Tsung-Ying1, Pruthvi Chennigahoshalli Revaiah1
1Department of Cardiology, University of Galway, University Road, Galway, H91 TK33, Ireland.
The international journal of cardiovascular imaging
|October 12, 2024
概括
一个新的名录预测PCI后的低于最佳的定量流量比率 (QFR) 使用程序前数据. 这种工具有助于临床医生做出重新血管化的决定,以获得更好的患者结果.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医学成像和诊断 医学成像和诊断
背景情况:
- 皮肤穿刺冠状动脉干预 (PCI) 后较高的定量流量比率 (QFR) 与改善的临床结果相关.
- 在血管学上成功的PCI后,用于识别次优QFR (<0.91) 的预测模型中存在差距.
研究的目的:
- 开发和验证一个可预测的诺姆图,用于PCI后QFR低于最佳.
- 帮助临床医生在重新血管化的决策.
主要方法:
- 总共使用了来自421名患者的450个容器,分为培训和内部验证集.
- 在一个单独的试验中,对95名患者的97个血管进行了外部验证.
- 使用LASSO和多变量逻辑回归来构建名图,通过AUC和校准来评估性能.
主要成果:
- 诺米图集成了量化流量比率衍生拉回压力梯度 (QFR-PPG) 与四个常规参数:LAD疾病,PCI前QFR,参考容器直径和直径百分比狭窄.
- 诺米图实现了AUC值为0.866 (培训),0.784 (内部验证) 和0.781 (外部验证).
- 校准曲线显示预测和观察结果之间存在很强的一致性.
结论:
- 一个包含五个PCI前变量的名图有效预测PCI后低于最佳QFR的风险.
- 经过验证的名图显示了指导重血管化策略的临床实用性.
- 该工具支持干预心脏病学方面的知情决策.
相关概念视频
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...